After senior business development roles in Glaxo and Roche he headed up Imperial College’s spinout activities, led the life science practice of UK venture capital manager MTI (who raised and managed a fund with The University of Manchester), and most recently was Director of Life Science Seed Funds at Cambridge University Enterprise. David holds degrees from King’s College London, Oxford University, and Harvard University.